Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Director · Chief Executive Officer | October 01, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 138,906 |
Ending reported balance
After 2026-10-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 18,750 · Balance 144,139 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Row 2 · 2026-10-01 · Exercise / conversion · Acquired 12,500 · Balance 156,639 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Row 3 · 2026-10-01 · Sale · Disposed 10,351 · Balance 146,288 F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). Row 4 · 2026-10-02 · Sale · Disposed 7,382 · Balance 138,906 F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 112,500 |
Reported balance
After 2026-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-01 · Exercise / conversion · Disposed 18,750 · Balance 112,500 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F4: The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 12,500 · Balance 25,000 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F5: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4: The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
F5: 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2025 Filed Apr 3, 2025 20:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 14,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000054 · wk-form4_1743711157.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,398 Underlying: Common Stock · 14,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 14,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000054 · wk-form4_1743711157.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| February 19, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 54,565 | $3.18 | $173,462.14 |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · nonDerivative · entry 4 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,072 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on February 16, 2025. The Reporting Person did not sell shares for any other purpose. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.31, inclusive. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 46,857 | $3.40 | $159,220.09 |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · nonDerivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,637 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on February 16, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.285 to $3.515, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4) in this Form 4. Read SEC document |
| February 16, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · derivative · entry 6 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. F6 · derivative.expiration_date: The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| February 16, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · derivative · entry 5 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. F5 · derivative.expiration_date: The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| February 16, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| February 16, 2025 Filed Feb 19, 2025 23:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000025 · wk-form4_1740007701.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 00:09 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000018 · wk-form4_1738282146.xml · derivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 24, 2025 Filed Jan 25, 2025 00:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 15,160 | $3.92 | $59,427.20 |
DisclosureSEC source: 0001666071-25-000016 · wk-form4_1737766668.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,494 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 23, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| January 23, 2025 Filed Jan 25, 2025 00:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000016 · wk-form4_1737766668.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date. F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date. Read SEC document |
| January 23, 2025 Filed Jan 25, 2025 00:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 43,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000016 · wk-form4_1737766668.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| January 03, 2025 Filed Jan 6, 2025 22:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,964 | $3.67 | $21,869.99 |
DisclosureSEC source: 0001666071-25-000002 · wk-form4_1736203724.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,904 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2025. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.555 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 14,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-25-000002 · wk-form4_1736203724.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,748 Underlying: Common Stock · 14,349 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 01, 2025 Filed Jan 6, 2025 22:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 14,349 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-25-000002 · wk-form4_1736203724.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 24, 2024 Filed Oct 25, 2024 00:01 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 22,607 | $3.85 | $86,923.92 |
DisclosureSEC source: 0001666071-24-000154 · wk-form4_1729814488.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,519 F2 · kind: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 23, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| October 23, 2024 Filed Oct 25, 2024 00:01 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000154 · wk-form4_1729814488.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| October 23, 2024 Filed Oct 25, 2024 00:01 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 43,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000154 · wk-form4_1729814488.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 11:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 7,543 | $3.09 | $23,270.16 |
DisclosureSEC source: 0001666071-24-000146 · wk-form4_1727953563.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,376 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 14,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000146 · wk-form4_1727953563.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,097 Underlying: Common Stock · 14,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 11:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 14,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000146 · wk-form4_1727953563.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000142 · wk-form4_1724359919.xml · derivative · entry 1 Gupta Amit · CIK 0001961238 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| July 24, 2024 Filed Jul 24, 2024 22:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 22,699 | $8.67 | $196,686.84 |
DisclosureSEC source: 0001666071-24-000123 · wk-form4_1721861831.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,569 F2 · kind: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 23, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.335 to $9.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| July 23, 2024 Filed Jul 24, 2024 22:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000123 · wk-form4_1721861831.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| July 23, 2024 Filed Jul 24, 2024 22:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 43,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000123 · wk-form4_1721861831.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 23:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 7,507 | $7.95 | $59,703.17 |
DisclosureSEC source: 0001666071-24-000119 · wk-form4_1719961919.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,518 F2 · shares: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.85 to $8.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 14,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000119 · wk-form4_1719961919.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,447 Underlying: Common Stock · 14,349 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 14,349 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000119 · wk-form4_1719961919.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| April 24, 2024 Filed Apr 24, 2024 23:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 23,416 | $11.91 | $278,884.56 |
DisclosureSEC source: 0001666071-24-000083 · wk-form4_1714000806.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,676 F2 · kind: Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 23, 2024. The Reporting Person did not sell shares for any other purpose. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $11.71 to $12.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 23:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000083 · wk-form4_1714000806.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,250 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the shares underlying the RSU award vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 23:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 43,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-24-000083 · wk-form4_1714000806.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 11:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 114,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000047 · wk-form4_1711366121.xml · derivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,796 Underlying: Common Stock · 114,796 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 24, 2024 Filed Jan 24, 2024 23:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 72,658 | $6.10 | $443,286.46 |
DisclosureSEC source: 0001666071-24-000020 · wk-form4_1706138478.xml · nonDerivative · entry 2 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,342 F1 · shares: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 23, 2024. The Reporting Person did not sell shares for any other purpose. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 23:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000020 · wk-form4_1706138478.xml · derivative · entry 3 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. F4 · derivative.exercise_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. F4 · derivative.expiration_date: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 23:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-24-000020 · wk-form4_1706138478.xml · nonDerivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2023 Filed Jan 23, 2023 21:40 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-23-000022 · wf-form4_167451000699274.xml · derivative · entry 1 Gupta Amit · CIK 0001961238 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: 50% of the RSUs shall vest on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over one year after the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: 50% of the RSUs shall vest on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over one year after the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.